Stay updated with breaking news from Mark pill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Widely. doctor david kessler is the chief science officer of the white house s covid-19 response, former fda commissioner. doctor kessler as i said, it is always an honor to have your time, especially on a night when i think a lot of americans have so many questions. thank you so much sir. thank you rachel. i should underscore with doctor kessler said about the fda advisory group tomorrow, considering the first of those two antiviral pills. these are treatments. that are going to the fda for potential approval. the first one is the mark pill, which is going to the fda advisory panel to more. after that it will be the pfizer one, to show even more effectiveness in clinical trials. that will be an important addition to what we have to fight this. this scourge. have a lot more ahead tonight, stay with us. stay with us for people living with h-i-v, keep being you. and ask your doctor about biktarvy. biktarvy is a complete, one-pill, once-a-day treatment used for h-i-v in certain adul ....
Right after you start having symptoms, 89% effective at reducing hospitalizations and death, that is off the charts. this is a new drug from pfizer, a couple of weeks ago you ll remember merck went to the fda to try to get approval for its covid treatment, its new anti viral pill, the data on the mark pill, frankly, looked great, it reduces hospitalization and death by 50%. but this other one that we just got the new data on from pfizer, it s not 50% effective, it s nearly 90% effective. that is potentially huge. a lot of people today observing this news call it a potential game-changer in terms of the pandemic, the people who have the broaddus horizons, the long term vision on this pandemic from the beginning have just been rejoicing today at this news. i mean, you put this into the broader picture, between the ....